Compound library / GI / Metabolic
Guanylate cyclase-C agonist peptide, FDA-approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation.
| Category | GI / Metabolic |
|---|---|
| Typical route | Oral |
| Half-life | Minimally absorbed systemically; acts locally in the gut |
| Common dose range | 72-290 mcg/day, per indication |
| Typical cycle length | Ongoing as needed for symptom control |
BioHack Track models Linaclotide (Linzess) at a half-life of 0.3 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Oral capsule; no reconstitution needed.
Store at room temperature; keep in original container away from moisture.
Prescription medication; not for use in patients under 6 (risk of serious dehydration); take on an empty stomach per label.
Track Linaclotide (Linzess) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Linaclotide (Linzess) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.